A potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease has been reported. - GreenMedInfo Summary
Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease.
Med J Aust. 2007 Aug 20 ;187(4):253. PMID: 17708735
No study abstract is available.